⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3126798 | 0.78 | — | — | |
| Hydrogen Peroxide SCHEMBL8376264 | 0.76 | ALDH1A1 (0.42) | — | |
| SCHEMBL35001 | 0.76 | — | — | |
| SCHEMBL23446 | 0.76 | — | — | |
| SCHEMBL19985 | 0.76 | — | — | |
| SCHEMBL2925945 | 0.76 | — | — | |
| Hydrogen Peroxide SCHEMBL28526372 | 0.76 | — | — | |
| SCHEMBL13785026 | 0.74 | TDP1 (0.38) | — | |
| Benzene SCHEMBL134227 | 0.74 | TDP1 (0.38) | — | |
| SCHEMBL8593374 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1828259-B1 | REMOVING FLUOROSURFACTANT FROM AQUEOUS FLUOROPOLYMER DISPERSIONS USING ANION EXCHANGE POLYMER WITH FUNCTIONAL GROUPS RESISTANT TO DEGRADATION TO TRIALKYLAMINES | DU PONT (US) | 2013-01-23 | — | — | EP | claimed |
| US-8329782-B2 | Removing fluorosurfactant from aqueous fluoropolymer dispersions using anion exchange polymer with functional groups resistant to degradation to trialkylamines | E I DU PONT DE NEMOURS AND COMPANY (US) | 2012-12-11 | — | — | US | claimed |
| US-20100093893-A1 | Removing Fluorosurfactant from Aqueous Fluoropolymer Dispersions Using Anion Exchange Polymer With Functional Groups Resistant To Degradation to Trialkylamines | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-04-15 | — | — | US | claimed |
| CN-101087816-A | Removing fluorosurfactant from aqueous fluoropolymer dispersions using anion exchange polymer with functional groups resistant to degradation to trialkylamines | DU PONT (US) | 2007-12-12 | — | — | CN | claimed |
| EP-1828259-A1 | REMOVING FLUOROSURFACTANT FROM AQUEOUS FLUOROPOLYMER DISPERSIONS USING ANION EXCHANGE POLYMER WITH FUNCTIONAL GROUPS RESISTANT TO DEGRADATION TO TRIALKYLAMINES | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2007-09-05 | — | — | EP | claimed |
| US-20060148972-A1 | Removing fluorosurfactant from aqueous fluoropolymer dispersions using anion exchange polymer with functional groups resistant to degradation to trialkylamines | THE CHEMOURS COMPANY FC, LLC | 2006-07-06 | — | — | US | claimed |
| WO-2006069104-A1 | REMOVING FLUOROSURFACTANT FROM AQUEOUS FLUOROPOLYMER DISPERSIONS USING ANION EXCHANGE POLYMER WITH FUNCTIONAL GROUPS RESISTANT TO DEGRADATION TO TRIALKYLAMINES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2006-06-29 | — | — | WO | claimed |
| US-8012466-B2 | Immunogenic compositions for activating γδ T cells | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2011-09-06 | — | — | US | disclosed |
| US-20100291118-A1 | Class of Gamma Delta T Cells Activators and Use Thereof | INNATE PHARMA (FR) | 2010-11-18 | — | — | US | disclosed |
| US-20100254940-A1 | Compositions and Methods for Regulating an Immune Response in a Subject | INNATE PHARMA, S.A. (FR) | 2010-10-07 | — | — | US | disclosed |
| US-7767842-B2 | Class of γδ T cells activators and use thereof | INNATE PHARMA SA (FR) | 2010-08-03 | — | — | US | disclosed |
| US-20100189681-A1 | Methods of Using Phosphoantigens Together with Interleukin-2 for the Treatment of Cancer | INNATE PHARMA S.A. (FR) | 2010-07-29 | — | — | US | disclosed |
| WO-2010049438-A2 | IMPROVED METHODS OF USING PHOSPHOANTIGENS FOR THE TREATMENT OF DISEASES | INNATE PHARMA (FR) | 2010-05-06 | — | — | WO | disclosed |
| EP-1689758-A2 | NEW CLASS OF GAMMA DELTA T CELLS ACTIVATORS AND USE THEREOF | Innate Pharma (FR) | 2006-08-16 | — | — | EP | disclosed |
| WO-2006067635-A2 | USE OF Ϝδ T LYMPHOCYTE ACTIVATORS AS VACCINE ADJUVANT | INNATE PHARMA S.A. (FR) | 2006-06-29 | — | — | WO | disclosed |
| WO-2005102385-A1 | ADJUVANT COMPOSITION AND METHODS FOR ITS USE | INNATE PHARMA (FR) | 2005-11-03 | — | — | WO | disclosed |
| EP-1569656-A2 | PHOSPHOANTIGENS FOR REGULATING AN IMMUNE RESPONSE | Innate Pharma (FR) | 2005-09-07 | — | — | EP | disclosed |
| WO-2005077411-A2 | COMPOSITION AND METHOD FOR THE TREATMENT OF CARCINOMA | INNATE PHARMA (FR) | 2005-08-25 | — | — | WO | disclosed |
| WO-2005054258-A2 | NEW CLASS OF GAMMA DELTA T CELLS ACTIVATORS AND USE THEREOF | INNATE PHARMA (FR) | 2005-06-16 | — | — | WO | disclosed |
| WO-2004050096-A2 | PHOSPHOANTIGENS FOR REGULATING AN IMMUNE RESPONSE | INNATE PHARMA (FR) | 2004-06-17 | — | — | WO | disclosed |